SCHEMBL32666822

SCHEMBL32666822

O=C1NCc2c1cc[nH]c2=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 2/20 0.48
DYRK1A Q13627 2/20 0.48
CLK4 Q9HAZ1 2/20 0.48
PIM1 P11309 1/20 0.48
CSNK1A1 P48729 1/20 0.48
ROCK1 Q13464 1/20 0.48
LRRK2 Q5S007 1/20 0.48
DYRK1B Q9Y463 1/20 0.48
LTK P29376 1/20 0.42
MST1R Q04912 1/20 0.42
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
MAP2K1 Q02750 1/20 0.40
MAPT P10636 2/20 0.38
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
PARP1 P09874 2/20 0.36
GRM2 Q14416 1/20 0.36
KDR P35968 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5320283 0.74
Hydrochloric Acid SCHEMBL5337159 0.72 CA12 (0.42) CDK5DYRK1ACLK4PIM1CSNK1A1
SCHEMBL30775288 0.69 KDR (0.61) CDK5DYRK1ACLK4PIM1CSNK1A1
SCHEMBL1335497 0.69 DYRK1A (0.61) CDK5DYRK1ACLK4PIM1CSNK1A1
SCHEMBL29532218 0.67 PARP1 (0.70) CDK5DYRK1ACLK4PIM1CSNK1A1
SCHEMBL6297545 0.67 PARP1 (0.70) CDK5DYRK1ACLK4PIM1CSNK1A1
SCHEMBL25134030 0.65 ROCK1 (0.47) CDK5DYRK1ACLK4PIM1CSNK1A1
SCHEMBL867264 0.65 PARP1 (0.68) CDK5DYRK1ACLK4PIM1CSNK1A1
SCHEMBL1078443 0.65 CDK5 (0.61) CDK5DYRK1ACLK4PIM1CSNK1A1
SCHEMBL24148319 0.65 CDK5 (0.61) CDK5DYRK1ACLK4PIM1CSNK1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028354-A1 TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS REGENT OF THE UNIV OF MICHIGAN (US) 2026-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028354-A1 TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS ESRRA, ESR2, ESRRB CDK5 3678/4885DYRK1A 1833/4885CLK4 4030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.